<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
NRXP
NRx Pharmaceuticals
$
()


  • NRx Pharmaceuticals prices $2M public offering at $3.30 per share

    4/18/2024 - 09:34am
  • NRx Pharmaceuticals demonstrates compliance with Nasdaq bid price rule

    4/18/2024 - 08:36am
  • NRx Pharmaceuticals announces common stock offering, no amount given

    4/17/2024 - 16:47pm
  • NRx Pharmaceuticals announces new data on NRX-101

    4/17/2024 - 08:35am
  • NRx Pharmaceuticals develops new proprietary formulation of HTX-100

    4/15/2024 - 08:34am
  • NRx Pharmaceuticals achieves data-lock of Phase 2b/3 trial of NRX-101

    4/8/2024 - 08:32am
  • NRX Pharmaceuticals trading halted, news pending

    4/1/2024 - 19:50pm
  • Fly Intel: Pre-market Movers

    3/28/2024 - 08:59am
  • NRx Pharmaceuticals sees FY23 EPS (40c), consensus (37c)

    3/28/2024 - 08:08am
  • NRx Pharmaceuticals announces 1-for-10 reverse stock split

    3/28/2024 - 08:05am
  • NRx Pharmaceuticals announces plan to distribute shares of HOPE Therapeutics

    3/18/2024 - 08:36am
  • NRx Pharmaceuticals initiates strategy to combat short sales

    3/12/2024 - 07:51am
  • NRx Pharmaceuticals completes MOU with distribution partners for HTX-100

    3/11/2024 - 08:35am
  • NRx Pharmaceuticals: Last patient, last visit in Phase 2b/3 trial of NRX-101

    3/4/2024 - 08:37am
  • NRx Pharmaceuticals announces $1M purchase agreement

    3/1/2024 - 08:35am
dynamic_feed Breaking News